Cyclic AMP (cAMP) synthesis in Escherichia coli is altered in cAMP receptor protein mutants and in phosphoenolpyruvate:sugar phosphotransferase transport system mutants. The stimulation of cAMP synthesis observed in cAMP receptor protein-deficient mutants is largely dependent upon enzyme III of the phosphoenolpyruvate sugar phosphotransferase transport system. The phosphoenolpyruvate:sugar phosphotransferase transport system enzyme I is not required for elevated cAMP synthesis. These results suggest that enzymne III plays an important role in regulating adenylate cyclase activity.
Cyclic AMP (cAMP) synthesis in Escherichia coli is altered in cAMP receptor protein mutants and in phosphoenolpyruvate:sugar phosphotransferase transport system mutants. The stimulation of cAMP synthesis observed in cAMP receptor protein-deficient mutants is largely dependent upon enzyme III of the phosphoenolpyruvate sugar phosphotransferase transport system. The phosphoenolpyruvate:sugar phosphotransferase transport system enzyme I is not required for elevated cAMP synthesis. These results suggest that enzymne III plays an important role in regulating adenylate cyclase activity.
Cyclic AMP (cAMP) is a major mediator of gene expression in bacteria (13) , yet regulation of its synthesis via adenylate cyclase is poorly understood at the molecular level. To date, most studies have been directed toward elucidation of the molecular mechanism underlying the control of adenylate cyclase activity by the phosphoenolpyruvate:glycose phosphotransferase transport system (PTS) (3, 10, 11) . By a genetic approach, it was found that the two common proteins of this phosphorylation cascade, enzyme I (encoded by ptsI) and Hpr (encoded by ptsH), are involved in regulation of adenylate cyclase activity. Moreover, enzyme III (encoded by crr), a component of the main PTS entry system for glucose, appears to be a key intermediate in this control (3, 11) .
Another type of regulation of adenylate cyclase activity involves the cAMP receptor protein (CAP). The first evidence for such a control was the observation that bacteria carrying a mutation or a deletion in the gene coding for CAP (crp or Acrp) were found to produce 20 to 100 times more cAMP than the corresponding crp+ strain (6, 14) . Conversely, cAMP synthesis is reduced in a crp mutant which synthesizes an altered CAP active in the absence of cAMP (5) . Since in Acrp strains the seemingly small increase in the adenylate cyclase activity measured in vitro (8) or in permeabilized cells (6) (about threefold) could not account for the large increase in cAMP synthesis in cultures, Joseph et al. (6) concluded that CAP regulates the activity rather than the synthesis of adenylate cyclase. The molecular control exerted by CAP has not yet been elucidated.
We questioned whether the PTS might play a role in the control of adenylate cyclase activity exerted by CAP. We therefore constructed two double mutants, Acrp ptsl and Acrp crr (Table 1) . We then compared the rates of cAMP synthesis in these strains to those obtained in the single Acrp, ptsI, or crr mutants and in the wild type ( Table 2) . As shown, the Acrp strain synthesized about 25 times more cAMP during exponential growth than the parental crp+ strain. Similarly, although the ptsI strain synthesized low levels of cAMP (3), its Acrp derivative displayed about the same rate of cAMP synthesis as the Acrp pstI+ strain. In contrast, the rate of cAMP synthesis found in cultures of the Acrp crr strain represented only 5 to 10% of that found with the two other Acrp strains.
These results show that activation of adenylate cyclase by lack of CAP requires a functional PTS enzyme III and does not require a functional PTS enzyme I. Consequently , this activation appears to be independent of phosphorylation of enzyme III by enzyme I. The remaining stimulation of cAMP synthesis found in a crr crp double mutant could be due to residual enzyme III activity in the crr mutant or it could be due to an independent mode of synthesis. What might be the mechanism of activation of the adenylate cyclase in the absence of CAP? We believe it unlikely that CAP interacts directly with adenylate cyclase. In fact, the study of various partial mutants of the crp gene (1) led us to suggest that CAP controls adenylate cyclase activity either via the transcription of a regulatory protein or by modulating the level of a regulatory metabolite (5) . (A hypothesis similar to the latter was also proposed by Dietzler et al. [2] for the control of glycogen synthesis by the cAMP-CAP complex). We further show here that the appearance of a large increase in the rate of cAMP synthesis in the absence of CAP is dependent on the presence of the PTS enzyme III, yet we cannot choose at the present time between the two following possibilities: (i) the presumably indirect control of adenylate cyclase activity exerted by CAP might involve enzyme III as a key intermediate; or (ii) the modulation of adenylate cyclase activity in the cell might result from the interplay of two different regulatory mechanisms, one involving enzyme III, the other involving CAP.
When CAP is lacking, enzyme III can activate adenylate cyclase in the absence of a functional enzyme I. This result, together with the fact that even in the presence of glucose as the carbon source large activation of adenylate cyclase occurs in the absence of CAP in a strain wild type for PTS (14; unpublished data), strongly suggests that apparently nonphosphorylated enzyme III can activate adenylate cyclase. These findings appear to contradict the simple model proposed by Postma (11) . According to this model, in the absence of glucose permeation into the cells, the phosphorylated form of enzyme III would activate adenylate cyclase.
In the presence of glucose, however, enzyme III, being predominantly in its nonphosphorylated form, could not activate the enzyme. We thus propose that some modulators, other than simply the state of phosphorylation of enzyme III through the PTS cascade, should be considered to account for the whole range of regulation of the adenylate cyclase activity. These putative modulators might act on aTransductions by P1 vir were performed as described in (1). LB, EMB, and M63 are described in (9 
